Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01368146 · ClinicalTrials.gov registry record · Phase 1
Human Repeat Insult Patch Test of Wound Dressings
A Phase 1 study of Skin Sensitization, sponsored by Covalon Technologies.
- Completed
- Registry status
- Phase 1
- Development phase
- 216
- Enrollment target
- 1
- Study location
NCT01368146 is a Phase 1 study of Skin Sensitization that has completed, run by Covalon Technologies. The registered enrollment target is 216 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01368146, a Phase 1 study of Skin Sensitization, has completed, sponsored by Covalon Technologies.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 216 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether contact sensitization occurs to the skin of normal healthy human subjects, by repetitive application of IV Clear™, Tegaderm CHG™ and Silicone Vehicle Control dressings.
Conditions Studied
Interventions
- DEVICE IV Clear™
- DEVICE Tegaderm CHG™
- DEVICE Silicone Vehicle Control Dressing
Study Locations (1)
Florida
- Hill Top Research - St. Petersburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 2011-03 |
| Est. Completion | 2011-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01368146
The ClinicalTrials.gov registry entry for NCT01368146 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 216 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Covalon Technologies, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Skin Sensitization appearing as the primary indexed condition, and to 3 interventions - of which IV Clear™ is the first listed.
NCT01368146 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT01368146 about?
NCT01368146 is a clinical study titled "Human Repeat Insult Patch Test of Wound Dressings". The purpose of this study is to determine whether contact sensitization occurs to the skin of normal healthy human subjects, by repetitive application of IV Clear™, Tegaderm CHG™ and Silicone Vehicle Control dressings.
What is the current status of trial NCT01368146?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 216 participants. The study started on 2011-03. Estimated completion is 2011-04.
What conditions does trial NCT01368146 study?
This clinical trial studies the following conditions: Skin Sensitization.
What interventions are being tested in trial NCT01368146?
The interventions under investigation include: IV Clear™ (DEVICE), Tegaderm CHG™ (DEVICE), Silicone Vehicle Control Dressing (DEVICE).
Who is sponsoring clinical trial NCT01368146?
This trial is sponsored by Covalon Technologies, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01368146 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.